Text-message support for depression in cancer survivors
Part of Cancer clinical trials.
This study is testing a text-message program to help cancer survivors who feel depressed get connected to mental health support. The goal is to see if this simple, phone-based approach makes it easier to follow up on a referral for depression care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with cancer.
- You have an appointment at an oncology clinic within the next two weeks.
- You speak English.
- You own a cellphone that can get text messages.
- You have been feeling down or hopeless recently (signs of depression).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a mobile app to help cancer survivors who are feeling depressed. If you have a smartphone and are willing to use an app for mood support, you may be able to join.
This study tests a program to help cancer survivors who are feeling depressed. It uses video calls and a smartphone app called Moodivate to check in with you, and you do not have to be in therapy to join.
This study tests if mindfulness messages sent by text can help reduce depression in people who have had cancer. You would receive simple exercises on your phone to do at home.
This trial tests an online therapy program for cancer survivors who feel anxious, depressed, or worried about cancer coming back. It's a text-based program you can do from home.
This study tests a follow-up program for cancer patients who visit the emergency department while receiving chemotherapy. The goal is to help prevent serious problems and improve care after you leave the hospital.
This trial tests a support program designed to improve quality of life for Chinese cancer patients and survivors. If you qualify, you'll join the program by phone or video call.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.